Tag

Pain Drug

All articles tagged with #pain drug

business5 months ago•2 min saved

Vertex Shares Drop 15% After Pain Drug Phase 2 Failure

Vertex Pharmaceuticals' stock dropped over 14% after the company announced it would not proceed with further testing of its pain drug VX-993 following disappointing midstage trial results, impacting its pain franchise. Despite beating quarterly sales and profit expectations driven by other products, the setback highlights challenges in expanding its pain treatment portfolio. The company also announced the retirement of its CSO, with a transition planned for early next year.

via Investor's Business Daily|

#biotech #business #journavx

health1 year ago•0 min saved

"Vertex's Non-Opioid Pain Drug Shows Promise in Late-Stage Trials"

Vertex Pharmaceuticals' experimental non-opioid drug, VX-548, has shown promising results in two Phase III studies, with over 1,000 participants each, by significantly reducing post-surgery pain levels compared to a placebo. The drug's success marks a potential breakthrough in the search for non-addictive pain medication.

via Endpoints News|

#health #non-opioid #pain-drug

pharmaceuticals2 years ago•1 min saved

"Vertex's Groundbreaking Drug Targets Global Market Potential, Says Cramer"

CNBC's Jim Cramer highlights Vertex Pharmaceuticals as a company to watch, as it develops a non-opioid drug, VX-548, to treat acute pain. Vertex aims to create a new class of prescription medications that address the addictive potential of opioids. Late-stage study results for VX-548 are expected within the year. Analysts at Leerink Partners believe the investment community underappreciates the potential of VX-548, comparing it to the obesity market a few years ago. Cramer's Charitable Trust owns shares of Eli Lilly, which expects its drug Mounjaro to expand its approved uses to obesity by year-end.

via CNBC|

#late-stage-trials #market-opportunity #opioid-alternative